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Abstract
Background: Colorectal cancer (CRC) has long been associated with bacteremia and/or endocarditis by
Streptococcus gallolyticus member bacteria (SGMB) but the direct colonization of SGMB along with its molecular
carcinogenic role, if any, has not been investigated. We assessed the colonization of SGMB in CRC patients with
history of bacteremia (CRC-w/bac) and without history of bacteremia (CRC-wo/bac) by isolating SGMB from feces,
mucosal surfaces of colorectum, and colorectal tissues and detecting SGMB DNA, via PCR and in situ hybridization
(ISH) assays targeting SodA gene in colorectal tissues. Moreover, mRNA of IL1, IL-8, COX-2, IFN-g, c-Myc, and Bcl-2 in
colorectal tissues of studied groups was assessed via ISH and RT-PCR.
Results: SGMB were found to be remarkably isolated in tumorous (TU) and non-tumorous (NTU) tissues of CRC-
w/bac, 20.5% and 17.3%, and CRC-wo/bac, 12.8% and 11.5%, respectively while only 2% of control tissues revealed
SGMB (P < 0.05); such contrast was not found in mucosal and fecal isolation of SGMB. The positive detection of
SGMB DNA in TU and NTU of CRC-w/bac and CRC-wo/bac via PCR, 48.7%, 35.9%, 32.7%, and 23%, respectively, and
ISH, 46.1%, 30.7%, 28.8%, and 17.3%, respectively, was higher than in control tissues, 4 and 2%, respectively
(P < 0.05). SGMB count measured via quantitative PCR of SGMB DNA in terms of copy number (CN), in TU and
NTU of CRC-w/bac and CRC-wo/bac, 2.96-4.72, 1.29-2.81, 2.16-2.92, and 0.67-2.07 log10 CN/g respectively, showed
higher colonization in TU than in NTU and in CRC-w/bac than in CRC-wo/bac (P < 0.05). The PCR-based mRNA
ratio and ISH-based percentage of positively stained cells of IL-1, 1.77 and 70.3%, COX-2, 1.63 and 44.8%, and IL-8,
1.73 and 70.3%, respectively, rather than IFN-g, c-Myc, and Bcl-2, were higher in SGMB positive patients than in
control or SGMB negative patients (P < 0.05).
Conclusions: The current study indicated that colorectal cancer is remarkably associated with SGMB; moreover,
molecular detection of SGMB in CRC was superior to link SGMB with CRC tumors highlighting a possible direct and
active role of SGMB in CRC development through most probably inflammation-based sequel of tumor
development or propagation via, but not limited to, IL-1, COX-2, and IL-8.
Background
Colorectal cancer (CRC) is the 4th most common cancer
worldwide [1]. Microorganisms were found to be either
etiological agents or play a prominent role in the etiol-
ogy of many types of cancer [2,3]. It has been shown
that bacterial infections are possibly linked to cancer by
two mechanisms: inflammation and/or formation of car-
cinogenic metabolites [4]. Therefore, it might be possi-
ble to prevent or treat cancer when the infectious
source can be identified [5].
One of the bacterial agents associated with cancer is
Streptococcus bovis (S. bovis). S. bovis has been found to
be important in human health as 25 to 80% of patients
with S. bovis bacteremia have also a colorectal tumor
and the association of colonic neoplasia with S. bovis
endocarditis has been shown to be 18 to 62% [6-9].
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It was shown that 94% of S. bovis bacteremia with color-
ectal cancer is associated with S. bovis biotype I while
only 18% is associated with biotype II [10]. Later, Osawa
et al in 1995 [11] proposed a new species resembling
S. bovis named S. gallolyticus. Interestingly, it was then
found that S. bovis biotype I and II/2 isolates are in fact
Streptococcus gallolyticus (S. gallolyticus) [12]. Accord-
ingly, S. bovis biotype I was replaced by S. gallolyticus
subspecies gallolyticus and biotype II/2 was replaced by
S. gallolyticus subspecies pasterianus and S. gallolyticus
subspecies macedonicus [13]. In the current study, these
three taxa were referred to as S. gallolyticus member
bacteria (SGMB) which have been found to be con-
stantly associated with underlying CRC [12].
Several studies conducted in Asia [14-16] found that
S. gallolyticus subspecies gallolyticus (S. bovis biotype I)
and S. gallolyticus subspecies pasterianus (S. bovis bio-
type II/2) are the main bacteria associated with colon
cancer in Asia. On the other hand, new studies con-
ducted in Germany [17] and Spain [18] found a remark-
able association between S. infantiarus coli (S. bovis II/
1) and colon cancer. Despite the geographical variation,
S. gallolyticus subspecies gallolyticus remains the main
bacterium associated with colon cancer worldwide.
No studies were conducted to assess the colonization
of SGMB in the colon by detecting SGMB DNA directly
in CRC tumors using advanced molecular assays. There-
fore, in the current study, SGMB-specific primers and
probes in PCR and in situ hybridization (ISH) assays,
respectively, together with the bacteriological isolation
of SGMB were pursued to detect/isolate SGMB DNA/
cells from feces, tumors’ mucosal surfaces, and tumors’
tissues.
Besides, the nature of SGMB association with CRC
was studied in this study since this association has not
yet been disclosed clearly. Very few studies [16,19,20]
were found to elucidate the underlying mechanism of
SGMB association with CRC. Some studies proposed
that this association is attributed to the access of SGMB
to the circulation via disrupted blood vessels in tumor
lesions [19]. However, the appearance of new colonic
lesions two to four years after the incidence of SGMB
bacteremia/endocarditis [21] and the association of
SGMB with preneoplsatic adenomas [16] provided evi-
dence that SGMB might not be a consequence of the
tumor lesion. Therefore, in an attempt to clarify the
possible role of SGMB colonizing colorectal tissues in
triggering, promoting, or propagating CRC, we selected
six key factors that might be linked to SGMB coloniza-
tion and CRC development. Accordingly, two key pro-
ducts of NFkB, namely, interleukin (IL) -1 and COX-2,
a central immunological regulator of inflammation, IFN-
g, a central oncogenic factor of CRC, c-Myc, an impor-
tant antiapoptotic factor, Bcl-2, and a potent angiogenic
factor, IL-8, were involved. It is well known that the
chronic inflammatory reaction in colorectal mucosa has
strongly been implicated in the development of CRC
and gastric cancer [19,20]. And it is also known that
70% of CRC is associated with overexpression of c-Myc
[22] and most CRC cases are associated with increased
antiapoptotic action via increased Bcl-2 expression [23].
And SGMB involvement in CRC patients were found to
be strongly associated with increased mRNA expression
of IL-8 and NFkB in CRC tumors [16].
Results
Demographic and histopathological features of CRC
The demographic and histopathological features of CRC
patients are shown in Table 1. The age and sex ratio of
CRC patients were found to be not associated with the
previous incidence of SGMB bacteremia, namely CRC-
wo/bac versus CRC-w/bac groups (P = 0.68 and 0.52,
respecitvley). In addition, CRC staging and tumor grad-
ing were also not associated with previous incidence of
Table 1 Demographic and histological characteristics of
control subjects and colorectal cancer patients
Controls
Mean age (years) 57.4 ± 4.7
Male: female ratio 1.18: 1
CRC-wo/bac patients (52 patients)
Mean age (years) 59.22 ± 8.18
Male: female ratio 1.2: 1





Tumor differentiation N (%) Grades 1-2: 21 (40.3)
Grades 3-4: 31 (59.6)
CRC-w/bac patients (39 patients)
Mean age (years) 56.6 ± 6.7
Male: female ratio 1.16: 1





Tumor differentiation N (%) Grades 1-2: 17 (43.5)
Grades 3-4: 22 (56.4)
Localization of tumors in CRC-w/bac and CRC-wo/bac patients (91
patients)
Left colon & rectum -N (%) 48/91 (52.7)
Rectum only - N(%) 15/48 (31.2)
Right colon -N (%) 31/91 (34)
Transverse colon -N (%) 12/91 (13.2)
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SGMB bacteremia, namely CRC-w/bac versus CRC-wo/
bac groups (P = 0.47 and 0.21, respectively).
Isolation of SGMB
The positive detection/isolation of SGMB and S. bovis
was found to be mostly impossible without using
enrichment media. The positive detection of fecal
SGMB was within the normal range, 2.5 to 15% [24].
The frequency of SGMB isolation from feces and muco-
sal surfaces of normal tissues in control population was
not different (P = 0.4). Most importantly, the frequency
of isolation of SGMB from feces and mucosal surfaces
of TU and NTU lesions in both CRC-wo/bac, and CRC-
w/bac groups was not different from the corresponding
control groups (P = 0.77, 0.42, 0.9, 0.71, 0.8, 0.8, respec-
tively) (Table 2).
Unlike the samples of feces and mucosal surfaces of
colorectum, SGMB isolated from colorectal tissues were
much higher in CRC patients than in control group.
High percentage of positive isolation of SGMB was asso-
ciated with TU (20.5%) and NTU (12.8%) of CRC-w/bac,
and TU (17.3%) and NTU (11.5%) of CRC-wo/bac while
very low percentage of positive SGMB isolation (2%)
was associated with control group (P = 0.0008, 0.013,
0.0027, 0.026, respectively) (Table 2, Figure 1). TU spe-
cimens showed close figures of positive isolation of
SGMB to that in NTU in both CRC-w/bac (P = 0.18)
and CRC-wo/bac groups (P = 0.24). It is worth mention-
ing that all CRC patients, whose fecal and mucosal sur-
face samples revealed positive isolation of SGMB,
showed also positive isolation of SGMB from colorectal
tumor tissues but the opposite was not true.
Regarding S. bovis, the percentage of its positive isola-
tion was minimal in feces and on the surfaces of color-
ectal mucosa while it was totally absent in colorectal
tissues in all groups (Table 2). The findings of API 20
Strep and Rapid ID32 Strep galleries confirmed the
results obtained by the bacteriological tests. All the iso-
lates diagnosed bacteriologically as S. gallolyticus from
feces, mucosal surfaces, and colorectal tissues were 88,
90.2, and 94.5%, respectively, of biotype I whereas the
rest of isolates were shown to be of biotype II/2. On the
other hand, all the isolates diagnosed as S. bovis were
shown to be of biotype II/1. Hence, the bacteriological
findings indicated that SGMB rather than S. bovis are
mainly associated with human bowel and colorectal tis-
sues. And SGMB were within normal percentages in
feces or on mucosal surfaces of CRC patients and con-
trol group. Nevertheless, SGMB in tumor lesions and
safe margins were remarkably found at high levels.
PCR-based detection of SGMB DNA in colorectal tissues
By gel electrophoresis, it was found that a single band of
408 bp PCR product was visible in all PSBS and PSBS-
tissue samples while it was absent in all NSBS and
NSBS-tissue samples (Figure 2). These findings con-
firmed the specificity of SodA gene primers for the
detection of SGMB DNA mixed with larger quantities
of DNA of human tissues or DNA of other bacteria
found in human bowel.
Since bacteriological methods revealed significant
colonization of SGMB in tumor tissues, but not in feces
or on mucosal surfaces, PCR-based detection of SGMB
DNA was pursued for colorectal tissues. PCR assay
revealed more remarkable results than that of bacterio-
logical assays. It was found that the positive detection of
SGMB DNA in CRC-wo/bac TU (32.7%) and NTU
(23%) tissues was higher than in colorectal tissues of
control group (4%) (P = 0.0005, p = 0.012, respectively)
(Table 3, Figure 1). More strikingly, the positive detec-
tion of SGMB DNA in CRC-w/bac TU (48.7%) and
NTU (35.9%) tissues was far higher than in colorectal
tissues of control group (4%) (P = < 0.0001, 0.0003,
respectively) (Table 3, Figure 1). There was no single
case where NTU was positive for SGMB DNA while the
corresponding TU was negative. However, the frequency
of positively detected SGMB DNA in TU versus NTU in
both CRC-wo/bac and CRC-w/bac groups was not
Table 2 Bacteriological isolation of SGMB and S. bovis from feces, mucosal surfaces and tissues of colorectum in
control, CRC-wo/bac, and CRC-w/bac groups
Group Positive isolation of fecal SGMB N (%) Positive isolation of mucosal SGMB N
(%)
Positive isolation of tissue SGMB N
(%)
TU NTU TU NTU
S. gallolyticus
Control (N = 50) 4 (8) 2 (4) 1(2)
CRC-wo/bac (N = 52) 5 (9.6) 4 (7.6) 2 (3.8) 9 (17.3) 6 (11.5)
CRC-w/bac (N = 39) 4 (10.2) 2 (5.1) 2 (5.1) 8 (20.5) 5 (12.8)
S. bovis
Control (N = 50) 2 (4) 1 (2) 0 (0)
CRC-wo/bac (N = 52) 2 (3.8) 1 (1.9) 1 (1.9) 0 (0) 0 (0)
CRC-w/bac (N = 39) 1 (2.5) 0 (0) 0 (0) 0 (0) 0 (0)
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Figure 1 A histogram showing a comparison in the percentage of the positive detection/isolation of SGMB among control, TU and
NTU tissues of CRC-wo/bac, and TU and NTU tissues of CRC-w/bac groups using three detection methods, namely SodA gene primer
PCR, S.g-sodA-probe ISH assay, and enrichment-based bacteriological methods. It is shown that the top SGMB detection method was PCR,
then ISH assay, and least effective was bacteriological isolation.
Figure 2 Gel electrogram of SodA gene-specific primer-based PCR products of normal colorectal tissues experimentally inoculated
with three PSBS strains (PSBS-tissue) and six NSBS strains (NSBS-tissue). PSBS-tissues (lanes A-C) were CIP 105428, CIP 105683, and CIP
105070, respectively while NSBS-tissues (lanes D-I) were CIP 108103, CIP 56.41, CIP 102504, ACM 3539, CIP 76117, and ATCC 25285, respectively.
PSBS-tissues, but not NSBS-tissues samples, yielded single band at 408 bp. The used ladder was QIAGEN GelPilot DNA Molecular Weight Marker.
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different (P = 0.22, 0.25, respectively). Moreover, no sig-
nificant association was found of the frequency of posi-
tively detected SGMB DNA, in both TU and NTU,
between CRC-wo/bac versus CRC-w/bac (P = 0.12, 0.18,
respectively) (Table 3, Figure 1). It is worth mentioning
that the positive detection of SGMB by PCR was not
associated with stage, grade, and location of tumors
(P = 0.13, 0.29, 0.48, respectively) or age and sex of
patients (P = 0.41, 0.22, respectively).
ISH-based detection of SGMB DNA in colorectal tissues
The positive detection of SGMB DNA via ISH assay was
achieved by visualizing SGMB as stained chains of tiny
spots scattered in tissue sections. The positive staining
was rarely seen as aggregations of stained spots or indi-
vidually scattered spots. S.g-sodA probe of ISH assay
yielded positive results in all PSBS-tissue sections, in
duplicates, while all the duplicates of NSBS-tissue sec-
tions were shown to be negative. Hence, these results
provided evidence on the high specificity of S.g-sodA
probe.
No characteristic localization or distribution of the
stained SGMB DNA was found throughout the tested
sections. Instead, stained chains of tiny spots were
shown to be scattered in tissue sections. SGMB DNA
staining in CRC-wo/bac TU (28.8%) and NTU (17.3%)
tissues was higher than in colorectal tissues of control
group (2%) (P = 0.0001, 0.015, respectively) (Table 4,
Figure 1) and it was far higher in CRC-w/bac TU
(46.1%) and NTU (30.7%) tissues than in colorectal tis-
sues of control group (2%) (P = < 0.0001, 0.0001,
respectively) (Table 4, Figure 1). There was no single
case where NTU was positive for SGMB DNA while the
corresponding TU was negative. However, the frequency
of positive staining of SGMB DNA in TU versus NTU
in both CRC-wo/bac and CRC-w/bac groups was not
different (P = 0.16, 0.16, respectively) and no significant
association was found in the positive staining of SGMB
DNA, in TU and NTU, between CRC-wo/bac versus
CRC-w/bac groups (P = 0.09, 0.13, respectively)
(Table 4, Figure 1). Since SodA gene primers have been
shown to be highly specific for SGMB, it was considered
as a golden standard for S.g-sodA probe- based ISH
assay. Accordingly, the sensitivity and specificity of
S.g-sodA probe- based ISH assay was 91.6 and 100%,
respectively, for TU tissue sections and 87 and 100%,
respectively, for NTU tissue sections. Hence, S.g-sodA
probe has been shown to be as specific as PCR assay
but with lower sensitivity. Like PCR, the positive detec-
tion of SGMB by ISH was not associated with stage,
grade, and location of tumors (P = 0.25, 0.11, 0.38,
respectively) or age and sex of patients (P = 0.26, 0.14,
respectively).
Quantification of SGMB DNA in colorectal tissues
Based on the positive detection of SGMB DNA, the
patients and controls of the current study were categor-
ized into two groups, SGMB+ve and SGMB-ve. For
SGMB+ve group, quantitative evaluation of SGMB colo-
nization was sought. The number of bacterial cells, in
terms of log10 CN/g, was compared among colorectal
tissues of the studied groups. First of all, the quantitative
real-time PCR confirmed the findings of the conven-
tional PCR without any variation. Above all, the quanti-
tative real-time PCR was successful in quantifying
SGMB in colorectal tissues of the studied groups.
SGMB load in CRC tissues was expressed as 95% CI of
mean log10CN/g (Table 5). The SGMB load in TU and
NTU of SGMB+ve-CRC-w/bac and TU, but not NTU,
of SGMB+ve-CRC-wo/bac was higher than that of
SGMB+ve-control group (P = < 0.000, 0.042, 0.03, 0.07,
respectively). And the difference in SGMB load between
TU and NTU, in both SGMB+ve-CRC-wo/bac and
SGMB+ve-CRC-w/bac groups, was significant (P = 0.01,
0.004, respectively). Moreover, SGMB load in TU, but
not NTU, in SGMB+ve-CRC-w/bac was higher than
that in SGMB+ve-CRC-wo/bac (P = 0.012, 0.2, respec-
tively). On the other hand, upon conducting the quanti-
tative real-time PCR, melting curve analysis of the
negative first derivative was pursued. It was found that a
Table 3 Detection of SGMB DNA using PCR assay of SodA
gene-specific primer in colorectal tissues of control, CRC-
wo/bac, and CRC-w/bac groups
Control (N = 50) N (%) CRC-wo/bac
(N = 52) N (%)
CRC-w/bac (N = 39)
N (%)
TU NTU TU NTU
2 (4) 17 (32.7) 12 (23) 19 (48.7) 14 (35.9)
Table 4 Detection of SGMB DNA using S.g-sodA probe-
based ISH assay in colorectal tissue sections of control,
CRC-wo/bac, and CRC-w/bac groups
Control (N = 50) N (%) CRC-wo/bac
(N = 52) N (%)
CRC-w/bac
(N = 39) N (%)
TU NTU TU NTU
1 (2) 15 (28.8) 9 (17.3) 18 (46.1) 12 (30.7)
Table 5 SGMB load in different groups of CRC tissues,
SGMB+ve- control, CRC-wo/bac, and CRC-w/bac by using
quantitative real-time SodA gene-specific PCR
SGMB+ve- control SGMB+ve- CRC-wo/bac SGMB+ve- CRC-w/bac
95% CI
(log10CN/g)
95%CI (log10CN/g) 95%CI (log10CN/g)








0.48-1.44 2.16-2.92 0.67-2.07 2.96-4.72 1.29-2.81
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single peak at the expected melting temperature of PCR
product, Tm 84.3°C, was observed while no significant
premature peaks were seen indicating that primer
dimers were minimal which provides further evidence
on the specific detection of SGMB.
The mRNA expression of IFN-g, COX-2, IL-1, IL-8, c-Myc,
and Bcl-2
The comparative results of mRNA level of the studied
cytokines and oncogenes among the involved groups of
CRC patients and control subjects were very similar in
both semi-quantitative real-time RT-PCR, in term of
mRNA ratio, and in ISH assay, in term of percentage of
the positively stained cells. For c-Myc and Bcl-2, the
mRNA expression was higher in TU, but not NTU, of
CRC patients than of control group and higher in TU
than in NTU in all CRC groups; nevertheless, no signifi-
cant difference was found in the level of mRNA expres-
sion of c-Myc and Bcl-2 regarding the history of
bacteremia or the positive detection of SGMB (Figure 3
and 4). For IL-8, mRNA level was higher in TU than in
NTU in all groups of CRC patients; IL-8 mRNA was
higher in TU and NTU of SGMB+ve groups in both
CRC-w/bac and CRC-wo/bac than in SGMB-ve groups;
and IL-8 mRNA was higher in TU and NTU of SGMB
+ve, but not SGMB-ve, in both CRC-w/bac and CRC-
wo/bac than in control group (Figure 3 and 4). On the
other hand, the mRNA level of proinflammatory cyto-
kines, IL-1 and COX-2, was at close levels between TU
and NTU of all CRC groups; it was significantly higher
in TU and NTU of SGMB+ve than in SGMB-ve groups
in both CRC-w/bac and CRC-wo/bac; and it was higher
in TU and NTU of SGMB+ve, but not SGMB-ve,
groups than in control group (Figure 3 and 4). Regard-
ing IFN-g, the mRNA level was not significantly differ-
ent between TU and NTU in all CRC groups, between
SGMB+ve and SGMB-ve groups in both CRC-w/bac
and CRC-wo/bac, and between control and all CRC
groups (Figure 3 and 4). Accordingly, the mRNA
expression of the studied agents revealed that inflamma-
tory cytokines, IL-1 and COX-2, were strongly asso-
ciated with SGMB colonization more than
transformation process itself while mRNA expression of
IFN-g was not shown to be related significantly with
transformation, SGMB, or TU versus NTU. On the con-
trary, the mRNA expression of oncogenic and anti-
apoptotic factors, c-Myc and Bcl-2, was associated with
the transformation process but not with SGMB coloni-
zation or safe margin tissues, namely NTU. Interestingly,
IL-8 proved to be of vital role in the carcinogenesis of
colorectal tissues; mRNA expression of IL-8 was asso-
ciated strongly with SGMB colonization, transformation
process, and TU versus NTU tissues. It is worth men-
tioning that mRNA level in either ISH assay or semi-
quantitative RT-PCR was not associated with age and
sex of CRC patients or with CRC stage, tumor grade, or
location of tumors. However, the mean mRNA ratio and
percentage of positively stained cells of Bcl-2 in B1, B2,
C1, and C2 stages collectively, 0.84 ± 0.23 and 21.6 ±
6.2% were much lower than in advanced D stage, 1.35 ±
0.12 and 58 ± 7.2, respectively (P = 0.01, 0.008
respectively).
Correlations among mRNA expression of cytokines and
with SGMB load
The mRNA ratio of IL-1 was positively correlated with
that of COX-2 in TU SGMB+ve-CRC-wo/bac
(r = +0.85, P = 0.002) and in TU SGMB+ve-CRC-w/bac
(r = +0.78, P = 0.003). The mRNA ratio of IL-8 was
positively correlated with that of COX-2 in TU SGMB
+ve-CRC-w/bac (r = +0.86, P = 0.001) and, to a lesser
extent, in TU SGMB+ve-CRC-wo/bac (r = +0.77,
P = 0.016).
One of the interesting findings, though might be pre-
dicted from the earlier results of the current study, the
bacterial load of SGMB, in terms of log10CN/g, was
positively correlated with mRNA ratio of IL-8 in TU
SGMB+ve-CRC-w/bac (r = +0.82.3, P = 0.01) and TU
SGMB+ve-CRC-wo/bac (r = +0.74, P = 0.02), COX-2
in TU SGMB+ve-CRC-w/bac (r = +0.83, P = 0.004),
and IL-1 in TU SGMB+ve-CRC-w/bac (r = +0.78, P =
0.01). Collectively, all positive correlations were
observed among IL-1, COX-2, and IL-8 in TU SGMB
+ve sections; moreover, the mRNA expression of these
three cytokines, rather than other studied agents, was
positively correlated with SGMB load in colorectal tis-
sues. This confirmed the earlier findings which pointed
out clearly to the remarkable association of IL-8,
COX-2 and IL-1 with SGMB colonization of colorectal
tumors.
Discussion
The association of SGMB, previously known as S. bovis,
with CRC has been reported to be 18 to 62% [6-9].
Hence, Beeching et al proposed that all patients with
SGMB bacteremia/endocarditis should be rigorously
investigated for the presence of a colonic tumor [25].
However, the association of SGMB with CRC has always
been described through the incidence of SGMB bactere-
mia and/or endocarditis. Little research has been done
on elucidating the direct relationship of SGMB with
tumor lesions of CRC to confirm or refute, on solid
bases, the direct link between CRC and SGMB.
In the current study, the association of SGMB with
CRC was confirmed by using biochemical tests, bacter-
iological isolation of SGMB, and detection of SGMB
DNA via PCR and ISH assay at tumor lesions compared
to normal colorectal tissues.
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SodA gene primer- based PCR and S.g.SodA probe-
based ISH assay were used. Although PCR assay proved
to be more sensitive than ISH, both assays yielded very
close findings. PCR and ISH assays succeeded in detect-
ing SGMB in colorectal TU and NTU tissues of CRC
patients much higher than in control tissues and fairly
higher, about two folds, than in the same tissues by
using bacteriological approach. In addition, quantitative
real-time PCR revealed significantly higher SGMB colo-
nization in the tissues of SGMB+ve CRC patients than
in control group, in TU than in NTU tissues, and in
SGMB+ve-CRC-w/bac than in SGMB+ve-CRC-wo/bac
groups.
The current findings of bacteriological and molecular
assays provided invaluable clues and new facts. First, the
bacteriological isolation of SGMB without enrichment
media was unsuccessful. With enrichment media, SGMB
were isolated in half of the colorectal tissues where
SGMB were detected by molecular assays. Almost all of
the previous studies explored SGMB colonization in
Figure 3 Normalized mRNA ratio, expressed as mean+ SE, of IL-1, IFN-g, COX-2, IL-8, c-Myc, and Bcl-2 is shown in TU and NTU tissues
of control, SGMB+ve-CRC-wo/bac, SGMB-ve-CRC-wo/bac, SGMB+ve-CRC-w/bac and SGMB-ve-CRC-w/bac. Significant differences in mean
mRNA ratio (P < 0.05) among different groups are shown as demarcation brace lines with corresponding P values whereas insignificant
differences are devoid of demarcation and P values.
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Figure 4 Mean+SE of positive mRNA staining via ISH assay for IL-1, IFN-g, COX-2, IL-8, c-Myc, and Bcl-2 is shown in TU and NTU
tissues of control, SGMB+ve-CRC-wo/bac, SGMB-ve-CRC-wo/bac, SGMB+ve-CRC-w/bac and SGMB-ve-CRC-w/bac. Significant differences in
mean of positive mRNA staining (P < 0.05) among different groups was shown as demarcation brace lines with corresponding P values whereas
insignificant differences were devoid of demarcation and P values.
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colorectum were conducted by using simple bacteriolo-
gical assays without using proper enrichment media
and, above all, they did not use molecular assays target-
ing SGMB DNA. This explains why previous studies
found either no evidence of SGMB colonization at tis-
sues of colorectal carcinomas [26] or low colonization
percentage, 11%, which was not significantly different
from that of mucosal 5.5%, or stool, 11%, samples [27].
The second essential clue of this study, the positive
detection of SGMB was confined only to TU and NTU
tissues of CRC patients rather than colorectal tissues of
control subjects. And the SGMB load, log10CFN/g, was
significantly higher in TU than in NTU colorectal tis-
sues. These findings suggest that there might be certain
kind of host-bacteria interaction involving both trans-
formed and adjacent histologically-normal tissues, and
this host-bacteria interaction could be of etiological role
in the carcinogenesis of CRC or of propagating factor in
tumor development. Klein et al stated that undefined
physical or biochemical factors in CRC tissues may
encourage S. bovis to be locally carcinogenic [28]. In a
study using animal models, the cell wall antigens of S.
bovis were found to promote premalignant lesions
through the increased formation of hyper-neoplastic
aberrant colonic crypts [19]. Moreover, S. bovis has been
shown to be able of causing a longstanding presence in
the bowel leading to chronic inflammation in the colon
[20]. Accordingly, such chronic bacterial infection/
inflammation may, in turn, contribute to cancer devel-
opment. In addition, it was also suggested that carcino-
genesis might issue when bacterial components interfere
with cell function [20].
The third essential clue of this study is that the pro-
ven colonization of SGMB in TU and NTU tissues of
CRC patients could explain why SGMB, more than
other dominant intestinal bacteria, can get access
through blood vessels into the circulation which in turn
leads to bacteremia and/or endocarditis. This interpreta-
tion, which was based on the findings of the current
study, supports what was suggested by other studies
that colonic lesions provide a suitable microenvironment
for S. bovis resulting in silent tumor-associated infec-
tions which become apparent when cancer patients
become immunocompromised, like in bacteraemia, or
have coincidental cardiac valve lesions, like in endocar-
ditis [16,24,25,29]. In addition, CRC patients with his-
tory of bacteremia showed higher frequency of SGMB
positive detection as well as higher titer of colonizing
SGMB than those without history of bacteremia which
provided evidence why some CRC patients develop bac-
teremia while others do not. Nevertheless, in the current
study, SGMB were not detected or isolated in a portion
of CRC patients with history of bacteremia. This could
be explained that SGMB in some CRC-w/bac patients
might be wiped out by antibiotic treatment during bac-
teremia/endocarditis phase or there might be individual
variation among CRC patients in their immunological
response to SGMB bacteremia leading to the eradication
of SGMB in some patients and the survival of SGMB in
others.
The fourth clue of this study, the colonization of
SGMB in CRC tumors and safe margin tissues rather
than normal tissues indicated that SGMB might possess
peculiar adhesive potential to malignant and premalig-
nant colorectal tissues. The findings of other studies
might explain the results of the current study. A study
found that S. bovis common antigen has the ability to
facilitate tumor attachment before translocation to the
bloodstream [30]. In addition, a histone-like protein A
in S. gallolyticus was found to bind this bacteria tightly
to colon tumor cell lines HCT116 and HT-29 [31].
Moreover, Sillanpaa team found that S. gallolyticus has a
distinctive ability to bind to all types of collagen pro-
teins in the extra-cellular matrix making S. gallolyticus
subspecies gallolyticus a successful colonizer in both
intestinal and cardiac tissues which might explain the
association between endocarditis and intestinal lesions
caused by this bacterium [32].
The fifth essential outcome of the current study is that
both SodA gene-specific primers and probe were suc-
cessfully used in PCR and ISH assays, respectively, for
designing highly sensitive detection tools for SGMB
colonizing colorectal tissues. Besides, the detection of
SGMB DNA showed that how extensively these bacteria
are involved in CRC disease and how the active role of
SGMB association with CRC have long been underesti-
mated because of the lack of using sensitive molecular
methods of detection.
To disclose the underlying nature of SGMB coloniza-
tion in colorectal tumors, mRNA expression of six cyto-
kines, chemokines and oncogenes were studied via two
different assays, ISH and semi-quantitative real-time
RT-PCR. Both assays turned out very similar patterns of
mRNA expression. Remarkably high mRNA expression
of two proinflammatory cytokines, IL-1 and COX-2, was
highly associated with SGMB+ve CRC patients equally
in both TU and NTU tissues while their level in SGMB-
ve CRC patients was low and close to that in control
group. This granted a peerless chance to highlight the
inflammatory potential of SGMB in colorectal tissues.
This finding supports the hypothesis that SGMB exert
chronic inflammatory reaction in bowel tissues which
might be one of the main factors for promoting or pro-
pagating the development of malignant or premalignant
lesions. These findings are in agreement with Ellmerich
study which showed that in vitro binding of S. bovis
wall extracted antigens to various cell lines stimulated
the production of inflammatory cytokines by those cells
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[33]. Moreover, it was stated that the production of
inflammatory cytokines in response to S. bovis including
IL-1b, TNF-a, and IL-6 as well as the chemokine IL-8
plays an important role in the normal defense mechan-
isms of the host [34] resulting in the production of
nitric oxide and free radicals such as superoxide, perox-
ynitrites and hydroxyl radicals [35]. Due to their
remarkable mutagenicity, these molecular species might
contribute to the neoplastic processes by modifying
cellular DNA.
Regarding the angiogenic chemokine, IL-8, it proved
to be exclusively essential in CRC, in general, and
SGMB-related CRC, in particular. The level of mRNA
expression of IL-8 was higher in SGMB+ve than in
SGMB-ve groups, higher in TU than in NTU groups,
and higher in CRC than in control groups. In other
words, IL-8 was shown to be associated with SGMB
colonization, transformation process, and local tumoro-
genesis altogether. This finding renders IL-8 as the most
important link between SGMB and carcinogenesis of
CRC. Jung et al showed that IL-8 was the most remark-
able chemokine expressed by human colon epithelial
cells when exposed to invasive strains of H. pylori bac-
teria [36]. Moreover, it was shown that IL-8 production
was induced by CRC cells exposed in vitro to Clostri-
dium difficile toxin A [37]. Interestingly, S. bovis were
previously shown to increase the production of IL-8
and, to a lesser extent, inflammatory cytokines in the
colonic mucosa of rats, suggesting direct interactions
between S. bovis and the colonic mucosal cells via IL-8
[33]. Therefore, IL-8 seems to be strongly related to
tumorogenesis when is induced or promoted by micro-
bial-driven inflammation. Because of the fact that IL-1
and COX-2 are products of NFkB activity [38], the cur-
rent findings regarding the association of IL-1, COX-2,
and IL-8 with SGMB+ve CRC confirmed the findings
of a previous study conducted by our team where
S. gallolyticus-seropositive CRC patients were signifi-
cantly associated with higher mRNA expression of both
NFkB and IL-8 [16]. In addition, it was shown in the
current study that COX-2 was positively correlated with
IL-1 and IL-8; moreover, IL-1, COX-2, and IL-8 were all
positively correlated with SGMB load in TU SGMB+ve
CRC patients. This provided extra evidence for the inte-
grative role of IL-1, COX-2, and IL-8 in SGMB-related
carcinogenesis of CRC. Hence, these cytokines and che-
mokines most probably act together by perpetuating the
SGMB-induced inflammation along with preparing a
strong angiogenic environment which is necessary for
the development and expansion of tumors.
For the mRNA expression of the oncogene c-Myc and
antiapoptotic Bcl-2, they were not associated with
SGMB colonization but were associated with CRC trans-
formation. This might imply that SGMB could have
nothing to do with inducing oncogenic changes or sup-
pressing cellular apoptosis. Therefore, SGMB more
probably act as a propagator factor for premalignant or
oncogene-positive tissues to enter the transformation
cycle through inflammatory and angiogenic microcli-
mates. However, this has not yet been confirmed and
further studies are needed to assess whether SGMB act
as carcinogenic or propagator factors for CRC develop-
ment. On the other hand, the immunological regulator
of inflammation, IFN-g, was not related with SGMB or
the transformation process of CRC. This might be
attributed to the immunosuppressive environment of
tumors that rendered IFN-g of equivocal effect on
SGMB colonization and CRC carcinogenesis.
Conclusions
Taken together, the current study showed clearly that
the colonization of SGMB do exist in TU and NTU tis-
sues of CRC patients, with or without history of bactere-
mia, while no such colonization was found in colorectal
tissues of control subjects suggesting an active role of
SGMB in CRC development. Besides, SGMB coloniza-
tion was heaviest in TU then in NTU and in CRC-w/
bac then in CRC-wo/bac highlighting that SGMB load
might be the main determinant for developing SGMB
bacteremia. Moreover, fecal and mucosal SGMB were
shown not to reflect reliably the status of SGMB coloni-
zation in colorectal tissues. On the contrary, molecular
assays detecting SGMB-specific SodA gene, via ISH and
PCR, proved to be reliable and much more sensitive
than bacteriological approaches. On the other hand,
SGMB colonizing colorectum appeared to induce
mRNA expression of proinflammatory cytokines, IL-1
and COX-2, as well as angiogenic chemokine, IL-8;
these cytokines and chemokines collectively provide
bases for promoting/propagating normal or premalig-
nant colorectal tissues into malignant status. It is
recommended to conduct further studies to clarify the
active role of SGMB in CRC development and pinpoint
the molecules in colorectal cells that interact with
SGMB leading to such active and, most probably, carci-
nogenic kind of bacterial colonization.
Methods
Population of the study
The involved CRC patients were selected from several
gastroenterology centers in the state of Selangor, Malay-
sia from February 2007 to July 2009. CRC patients were
subjected to surgical resection of colorectal cancer and
were categorized into two groups, CRC patients with a
history of S. gallolyticus/bovis bacteremia in the last
2 years, named as CRC-w/bac, and CRC patients with-
out bacteremia/endocarditis, named as CRC/wo-bac.
However, antibiotics taken at the time of bacteremia/
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endocarditis might still be interfering with the results of
the study; therefore, the patients of CRC-w/bac group
included in this study were those who were treated
from bacteremia/endocarditis by intravenous antibiotics,
at least 3 months before conducting surgery in order to
minimize antibiotic-driven effect on SGMB colonization,
if any. Fifty two CRC-wo/bac, 29 men and 23 women
aged between 45 to 78 years and 39 CRC-w/bac,
21 men and 18 women, aged between 42 to 81 years
with primary colorectal adenocarcinoma were involved
in the current study before administration of che-
motherapy. CRC patients were examined and their
health records were reviewed. The patients who revealed
no major illness or gastrointestinal disorder other than
CRC and did not receive any antibiotic for the last 3
months, including CRC-w/bac, were only recruited in
the current study. On the other hand, 50 age- and sex-
matched control subjects were selected from those who
were subjected to colonoscopy and their colonic mucosa
were shown to be free of gastrointestinal lesions. More-
over, no gastrointestinal or major disease was found in
control subjects after conducting a thorough medical
examination and after retrieving their medical and surgi-
cal history. Colonoscopical biopsies were taken from
control subjects for comparing them with excisional
biopsies of CRC patients. CRC patients involved in this
study were presented at all stages of the disease, B1 to
D. Written consents were obtained from the partici-
pants. The study was carried out in the scope of
Helsinki declaration of ethical principles of medical
research and permission was granted from the Ethics
Committee of biomedical research.
Standard bacterial strains
Three different members of SGMB which are genetically
close to each other were used as positive standard bac-
terial strains (PSBS), namely S. gallolyticus subspecies
gallolyticus CIP 105428 (ACM 3611), S. gallolyticus sub-
species macedonicus CIP 105683, and S. gallolyticus sub-
species pasteurianus CIP 105070. On the other hand,
closely related taxa and dominant intestinal species of
bacteria that are rarely associated with CRC were
included as negative standard bacterial strains (NSBS).
NSBS included S. lutetiensis strain CIP 108103, S. pyo-
genes strain CIP 56.41, S. equinus strain CIP 102504,
S. bovis ACM 3539, Enterococcus faecalis CIP 76117,
and Bacteroides fragilis ATCC 25285. PSBS and NSBS
were used to double check the specificity of the already
tested [39] manganese-dependent superoxide dismutase
(sodA) gene-specific primers and sodA gene-specific
probe at the conditions of the pursued assays of PCR
and in situ hybridization (ISH), respectively. All the
strains of PSBS were cultured at 37°C on Columbia
blood agar (Oxoid Ltd., UK) with 5% horse blood while
NSBS bacteria were cultured according to the corre-
sponding media for each species.
Specimens of colorectal mucosa and tumors
The excisional biopsies of tumor lesions that were taken
from CRC patients after surgery and the colonoscopy
punch biopsies that were taken from control group were
prepared for four different processing pathways: bacter-
iological isolation of SGMB, DNA extraction for con-
ventional and quantitative real-time PCR targeting DNA
of SGMB, mRNA extraction for semi-quantitative real-
time RT-PCR of IL-1, IL-8, IFN-g, COX-2, c-Myc, and
Bcl-2, and in situ hybridization (ISH) assay for the
detection of S. gallolyticus SodA gene, IL-1, IL-8, IFN-g,
COX-2, c-Myc, and Bcl-2 nucleotides. By a histopathol-
ogist, biopsies from CRC patients were categorized into
2 groups, tumorous, TU, (from tumor lesion itself) and
non-tumorous, NTU, (from histologically tumor-free
resection margins). In addition, fecal samples were col-
lected from control subjects as well as from CRC
patients preoperatively for assessing and enumerating
fecal S. gallolyticus/bovis bacteria.
Isolation of SGMB
SGMB were subjected for isolation from fecal material
and colorectal tissues. The isolation and differentiation
of target bacteria were based on the protocols of Devri-
ese et al. [12]. For the bacteriological tests, terms like
S. gallolyticus and S. bovis were used rather than SGMB
because, by using bacteriological tests, it is difficult to
differentiate target bacteria into the molecular-based
new terminology used in this study. However, by using
API biochemical tests, bacteriologically-proven S. gallo-
lyticus were shown to cover SGMB, namely S. bovis I
and II/2, or S. gallolyticus gallolyticus and S. gallolyticus
pasterianus, while bacteriologically-proven S. bovis were
shown to represent non-SGMB family, more precisely
S. bovis biotype II/1 or S. infantarius bacteria. For the
preparation of specimens, 5 g of feces were 1:5 diluted
in brain heart infusion broth (Oxoid, UK) with 5%
bovine blood (Oxoid, UK) for 18-24 h at 37°C. For col-
orectal tissues, 5 g were rinsed thoroughly with shaking
for 5 min in 30 ml of PBS for the recovery of mucosally
attached target bacteria and PBS was then centrifuged at
3,000 × g for 5 min at 15°C. The pellet was then resus-
pended in 1 ml of brain heart infusion broth and
Columbia agar with 5% bovine blood for 18-24 h at
37°C. On the other hand, for bacteria infiltrating color-
ectal tissues, the rinsed colorectal tissues (5 g) were
washed thoroughly three times with PBS to get rid of
any remaining surface bacteria and were then homoge-
nized mechanically and incubated in brain heart infu-
sion broth and Columbia agar with 5% bovine blood for
18-24 h at 37°C. Enriched bacteria were then grown on
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two selective media, Slantez and Bartley agar (Oxoid,
UK) and Edwards agar with 5% bovine blood (Oxoid,
UK) at 42°C; plates were incubated in air and supple-
mented with 5% CO2 which increased growth of all
strains. S. gallolyticus was differentiated from S. bovis in
selective media by colony morphology and color [12]. In
Slantez Bartley medium, dark red colonies were diag-
nosed as Enterococcus, small white colonies as S. bovis,
and small pale pink colony as S. gallolyticus. For
Edwards agar, S. gallolyticus, unlike S. bovis, was grown
without brown-black discoloration. In addition, for con-
firming the identity of target bacteria in terms of
S. bovis I, II/1, or II/2, API 20, Strep and Rapid ID32
Strep galleries (BioMérieux, La Balme les Grottes,
France) were used. Moreover, solution of 6.5% NaCl was
also used for salt tolerance [12].
DNA and RNA extraction of colorectal biopsies
DNA extraction was done according to the instructions
of TRI-zol kit (invitrogen, USA) which is a modification
of Guanidium Isothiocyanate method. First, a piece of
colorectal tissue was put in a tube containing 300 μl
Tri-Zol solution. The tissue was minced using the tip of
a pointed pincet then vortexed for 1 minute. The tube
was left for 5 min at room temperature. Into the tube,
80 μl of chloroform (Merck, Germany) were added. For
DNA isolation, the organic phase was then pipetted into
a new tube containing 200 μl of protein precipitation
solution (Promega, USA) to purify the genomic DNA
and the resulting reaction mixture was vigorously vor-
texed for 20 s. Afterwards, the mixture was incubated in
ice for 5 min, and centrifuged at 13,000 × g for 3 min at
4°C. The supernatant was carefully transferred into a
clean 1.5 ml microcentrifuge tube containing 200 μl of
absolute ethanol. The tube was shaken and left for 1 h
in 2-8°C. DNA was sedimented by centrifuging in 8,000
× g for 10 min at 4°C and was washed twice using 75%
ethanol (Merck, Germany). It was dried for 30 min at
room temperature. DNA was suspended using 100 μl
DNA rehydration solution (Promega, USA) [40,41].
DNA yield was 10 to 12 μg; the absorbance ratio of
260/280 nm was > 1.8 and DNA quality was assessed
further by gel electrophoresis. For RNA isolation, the
aqueous part was removed to a Rnase-free 1.5 ml micro-
centrifuge Tube (Invitrogen, USA) and RNA was preci-
pitated by adding 0.5× volume of 100% room
temperature ethanol [42]. Then, RNA was purified by
using QIAGEN RNeasy Mini Kit (QIAGEN, Germany);
the procedure was conducted according to the protocol
outlined in the RNeasy Mini Handbook [43]. Average
RNA yield was 4 to 6 μg and absorbance ratio of 260/
280 nm was > 1.8. RNA quality was assessed using Agi-
lent 2100 Bioanalyzer with RNA LabChip kit (Agilent,
USA).
DNA extraction of standard bacteria
DNA of the standard bacteria was extracted using
Wizard® Genomic DNA Purification Kit with accessory
reagents (Promega, USA); the method of extraction was
done according to the manufacturer’s instructions. The
obtained genomic DNA was re-hydrated by adding 100
μl DNA Rehydration solution. Extracted DNA 260/280
nm ratio was > 1.8 and quality was assessed by gel
electrophoresis.
The specificity of SodA gene primers
The primers designed for the current study were used in
both conventional and quantitative real-time PCR for
the detection of SGMB DNA. The forward primer, 5′-
CAATGACAATTCACCATGA-3′, is composed of 19
bases whereas the reverse primer, 5′-TTGGTGCTTT
TCCTTGTG-3′, is composed of 18 bases. These primers
were already tested by a previous study [39] by which
these primers were shown to be highly specific in target-
ing SodA gene for the identification of 23 strains of
SGMB including S. gallolyticus, S. pasteurianus and S.
macedonicus strains while these primers were shown to
be negative for S. infantarius, S. salivarius, and S.
equines [39]. Because these primers were first designed
in 2004 and gene bank is expanding progressively every
year, the specificity of these primers was rechecked by
our team in 2008 and 2009 using Genbank BLAST-Pri-
mer program which reconfirmed that these primers are
highly specific for SGMB DNA. The nucleotide
sequences of sodA gene in S. gallolyticus subspecies gal-
lolyticus, S. gallolyticus subspecies pasterianus, and S.
gallolyticus subspecies macedonicus were the only
sequences showing complete complimentarity with the
tested primers yielding a product of 408 bp, Tm 84.4 C,
and GC content 44.3%. The accession numbers of
nucleotide sequences that showed complete complimen-
tarity were: FJ617234, FJ617229, FJ617228, FJ042703,
FJ151363, FJ151362, FJ151361, FJ151360, FJ151359,
FJ151357, FJ151355, DQ232583, DQ232578, DQ232549,
AY035715, AY035714, AJ297211, AJ297209, AJ297208,
AJ297206, AJ297204, AJ297202, AJ297201, AJ297200,
AJ297199, AJ297198, AJ297197, AJ297196, AJ297195,
AJ297193, AJ297192, AJ297191, AJ297190, AJ297183,
FJ617226, FJ151367, and AY315154. Other strains and
species, including homo sapiens, were non-complimen-
tary to the tested primers.
In the current study, for more confirmation, the sodA
gene primers were tested on PSBS that are supposed to
be recognized by these primers and NSBS that are not
supposed to be recognized by these primers by using
conventional PCR assay on DNA extracted from PSBS
and NSBS via Wizard® Genomic DNA Purification Kit.
Moreover, to simulate DNA extracted from colorectal
tissues, SodA gene primers were tested on DNA
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extracted from PSBS or NSBS-inoculated colorectal tis-
sue biopsies of control group via TRI-zol kit, which
were named PSBS-tissue and NSBS-tissue, respectively.
Conventional PCR for bacterial sodA gene
The PCR protocol used was based on a previous study
[39] with modifications applied after frequent optimiza-
tion runs. Two μl, in duplicates, of DNA extracted from
PSBS and NSBS, DNA extracted from PSBS-tissue and
NSBS-tissue, and DNA extracted from colorectal tissues
of CRC and control subjects were added to the PCR
master mixture, which consisted of 2 μl of 10× PCR
buffer, 0.8 μl of a 10 mM deoxynucleoside triphosphate
mixture, 0.7 μl of forward and reverse primers at con-
centration of 10 pmol/μl, 1.5 μl of 25 mM MgCl2, and
0.2 μl of 0.5 U Taq DNA polymerase; the remaining
volume consisted of distilled water. All the reaction mix-
tures were obtained from (Promega, USA). The reaction
mixture in microcentrifuge tube was amplified in a ther-
mocycler PCR system (PTC-110TM Model, MJ
Research, Inc., USA). The PCR protocol consisted of an
initial denaturation at 95°C for 5 min with 30 cycles of
denaturation at 94°C for 60 s, annealing at 52°C for
30 s, and extension at 72°C for 30 s; and a final exten-
sion at 72°C for 8 min. Afterwards, 5 μl of PCR pro-
ducts were electrophoresed on 2% agarose gel using
QIAGEN GelPilot DNA Molecular Weight (Qiagen,
Germany) as a ladder. PCR products were separated by
an electrophoresis system at a constant voltage of 80 V
for 50 min and were stained with 0.25 μg/ml ethidium
bromide (Sigma, USA). PCR products were photo-
graphed under UV transilluminator (Vilber Lourmat,
Cedex, France) and the photos were taken using gel
documentation system, Bio Rad Gel Doc 2000 Model
Imaging System (Bio-Rad, USA). PCR assay yielded an
amplicon of 408 bp. Positive control, in duplicate, was
included containing DNA from reference S. gallolyticus
subsp. gallolyticus CIP105428, whereas negative control,
in duplicate, was included containing all PCR reactive
agents except for template DNA.
Standard curve of real-time PCR
The purified PCR product of interest, 408 bp, obtained
from streptococcus gallolyticus subsp. gallolyticus
CIP105428 was ligated into pGEM®-T Easy Vector (Pro-
mega, USA) which consisted of a mixture of 2× rapid
ligation buffer, pGEMTR Easy Vector, purified PCR pro-
duct, T4 DNA ligase and sterile distilled water. Escheri-
chia coli competent cells of strain JM 109 were used to
carry pGEM®-T Easy Vector (Promega, USA). The plas-
mid DNA along with PCR product insert was then
extracted according to the manufacturer’s instructions
using Wizard® Plus SV Minipreps (Promega, USA). The
initial concentration of the plasmid DNA of interest was
8.3 μg/ml. The plasmid with the correct insert was then
10-fold serially diluted up to 8 dilutions. Since the mole-
cular weight of the plasmid DNA is known, the concen-
tration of these dilutions were then transformed into log
copy number (log CN), defined as SGMB load, which
was plotted against the threshold cycle (Ct) to generate
the standard curve used for the absolute quantification
by real-time PCR. Moreover, the plasmid DNA of inter-
est was used as positive control while the negative
control was managed to be devoid of template DNA.
Quantitative real-time PCR for bacterial sodA gene
For quantitative assessment of SGMB load in colorectal
tumor biopsies, absolute quantitative real-time PCR was
designed using the same sodA gene primers used in the
conventional PCR with modifications. Real-time PCR
amplification reaction was performed with Rotor-Gen-
eTM 3000 (Corbett. Research, Australia) using fluores-
cent dye SYBR Green (QiagenTM QuantiTect® SYBR
Green PCR kit). The reaction was performed in a total
volume of 25 μl (2.5 μl of 10× PCR buffer); the compo-
sition of the reaction mixture per sample was as follows:
1.8 μl of 25 mM MgCl2, 0.7 μl of 10 mM dNTP, 9.5 μl
SYBR Green, 1.5 μl of 25 μM reverse and forward pri-
mers, 0.125 μl of 5 U/μl Taq DNA polymerase, 5.0 μl
DNA template (~16 ng), and the rest was RNase free
water. All the reaction mixtures were obtained from
Promega (Promega, USA). PCR protocol consisted of an
initial denaturation at 95°C for 5 min; 35 cycles of dena-
turation for 60 s at 94°C, annealing for 30 s at 52°C, and
extension for 30 s at 72°C; and a final extension cycle
for 8 min at 72°C. The serially diluted standards, posi-
tive and negative controls, and samples were all simulta-
neously assayed, in duplicates, during real-time
amplification. At the end of amplification, measurement
of the SYBR Green fluorescence was done continuously
through conducting the melting curve analysis by slow
heating at 0.2°Cs-1 increments from 60 to 99 °C, with
continuous fluorescence collection. Accordingly, a melt-
ing curve was generated at the end of the PCR amplifi-
cation for monitoring the specificity of PCR reaction.
Semi-quantitative real-time RT PCR for IFN-g, COX-2, IL-1,
IL-8, c-Myc, and Bcl-2
One-step RT-PCR was used; 250 ng of RNA were
reverse transcribed into cDNA for 10 min at 55°C [44].
Real-time PCR amplification reaction was performed
with Rotor-GeneTM 3000 (Corbett. Research, Australia)
using fluorescent dye SYBR Green (QiagenTM Quanti-
Tect® SYBR Green PCR kit). Gel electrophoresis and
melting curve analysis at 0.2°Cs-1 increments from 60
to 99°C were used for confirming reaction specificity.
Human b-actin mRNA was used as an internal control.
Amplification was done in a volume of 20 μl for
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40 cycles with preliminary 10 min denaturation phase at
95 °C and a final 72°C extension phase for 8 min. The
manufacturers and sequences of the used primers
together with the corresponding PCR protocols are
shown in Table 6. The mRNA expression of target or
reference samples was normalized to the mRNA expres-
sion of the corresponding human b-actin. The relative
expression of the studied mRNA molecules was deter-
mined by relating the normalized expression of each tar-
get, in duplicates, to the normalized expression of a
reference sample to calculate a fold-change value in
term of mRNA ratio. Positive controls of the studied
targets were supplied by the primers’ manufacturers and
were all tested to yield consistent positive results
whereas the negative controls were those samples pre-
pared without DNA template.
Probes used for in situ hybridization assay
For the detection of SodA gene DNA via ISH assay,
SodA gene-specific biotinylated probe was designed
according to the nucleotide sequence accession no.
AJ297183 by using megablast and discontiguous mega-
blast algorithms for alignment similarity (GenBank,
BLAST). The probe size is 435 bp of linear DNA tar-
geted for sodA gene of superoxide dismutase of S. gal-
lolyticus subspecies gallolyticus (strain CIP 105428T,
ACM 3611). This probe was named as S.g-sodA probe.
It was synthesized and biotinylated by (Promega
laboratories, USA). S.g-sodA probe was designed to be
highly specific for S. gallolyticus subspecis gallolyticus,
S. gallolyticus subspecis pasteurianus , and S.
gallolyticus subspecies macedonicus while it was
designed to be incompatible with other related taxa of
bacteria, or other organisms’ genomes including Homo
sapiens. This design is necessary to avoid mispriming
with DNA of other bacteria or of huamn colroectal tis-
sues. For more confimration, the specificity of S.g-
sodA probe was assessed by our team by using ISH
assay on duplicates of three strains of PSBS-tissue and
six srtains of NSBS-tissue sections at identical condi-
tions to these used for test sections. The strains of
PSBS-tissues were CIP 105428, CIP 105683, and CIP
105070 while the strains of NSBS-tissues were CIP
108103, CIP 56.41, CIP 102504, ACM 3539, CIP
76117, and ATCC 25285.
For the mRNA detection of targeted cytokines and
oncogenes via ISH assay, biotinylated long cDNA probes
were used including human mRNA of IFN-g (MaxHyb
Probe, human IFN-g, PB-60088, probe size 423 bp, Gen-
Bank Accession No: NM_000619, Maximbio, USA),
COX-2 (MaxHyb Probe, human COX2, PB-60161,
probe size 278 bp, GenBank Accession No: BC013734,
Maximbio, USA), Bcl-2 (MaxHyb Probe, human Bcl-2,
PB-60010, probe size 235 bp, GenBank Accession No:
M14745, maximbio, USA), c-Myc (MaxHyb Probe,
human c-Myc, PB-60052, probe size 1181, GenBank
Accession No: V00568, Maximbio, USA), IL-1b (Max-
Hyb Probe, human IL-1b, PB-60089, probe size 196 bp,
Genbank accession no. NM_000576, Maximbio, USA),
and IL-8 ((MaxHyb Probe, human Interleukin 8, PB-
60092, probe size 299 bp, Genbank accession no.
NM_000584, Maximbio, USA).
Table 6 Details of the primers used for the amplification of IL-1, IFN-g, COX-2, IL-8, c-Myc, and Bcl-2 with the
corresponding targets and PCR conditions
Target Primer sequence PCR conditions Manufacturer Reference

















20 s 95°C, 60 s 60°C, 30 s 72 s Promega, [49]
IL-8 F-TAGCAAAATTGAGGCCAAGG
R-GGACTTGTGGATCCTGGCTA





95°C 3 min, 40 cycles 95°C 30 s, 58°C 30 s,
and 73°C 30 s
Promega, USA [51]
b-actin for IFN-g and c-Myc F-5’-GATGGCCACGGCTGCTT-3’
R-5’-ACCCTCATTGCCAATGGT-3’











30 s 95°C, 70 s 60°C (annealing/extension). Maximbio,
USA
[50]
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In situ hybridization for SodA gene, IFN-g, COX-2, IL-1,
IL-8, c-Myc, and Bcl-2
Proper histopathological processing necessitated several
steps to be pursued by the pathologist to minimize the
fixation-associated loss of mRNA including minimal pre-
fixation time, up to one hour, using cold 4% paraformal-
dehyde, cold fixation at 4°C, and short duration of
fixation, up to 5 h [45]. Paraffin-embedded sections were
Figure 5 Examples of ISH staining of mRNA of IL-1, IFN-g, COX-2, IL-8, c-Myc, and Bcl-2. Cells stained positive are shown with dark color
of NBT/BCIP in the nuclei of glandular cells as well as stromal cells. mRNA expression of IL-1 (A-C) at X100, IFN-g (D-F) at 400X, COX-2 (G-I) at
X100, and IL-8 (J-L) at 100X, is shown in control, TU SGMB+ve-CRCw/bac, and TU SGMB-ve-CRC-w/bac, respectively. mRNA expression of c-Myc
(M-O) at X400 and Bcl-2 (P-R) at X400 is shown in control, TU SGMB-ve-CRC-wo/bac, and NTU SGMB-ve-CRC-wo/bac.
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processed for ISH assay within 3 days before the exami-
nation because it was reported that no remarkable loss of
nucleic acids is found in the first three days of fixation
and paraffin embedding [46]. Histopathological paraffin
blocks, whether for CRC patients or control subjects,
were processed into sections of 4 um thickness. From
both TU and NTU tissues, numerous histopathological
sections were made for each CRC patient. Hematoxylin
and Eosin slides were prepared by the pathologist to con-
firm the histopathological diagnosis and the grading of
CRC. One negative control tissue section was used at
every run of ISH by using diluent buffer instead of
probes. In addition, a consistently and strongly positive
section was used as positive control along with one endo-
genous positive probe control. The procedure was pur-
sued according to “DNA probe Hybridization/Detection
System - in situ Kit” (Maximbio, USA) with some modifi-
cations according to Abdulamir et al [16].
Staining analysis
For mRNA expression of the studied cytokines, chemo-
kines, and oncogenes, the percentage of stained glandu-
lar and stromal cells with blue/black nuclear staining
was calculated out of total cells in 5 high power fields.
Regarding IFN-g, IL-1, IL-8, COX-2, c-Myc, and Bcl-2,
many scoring systems, sometimes contradicting, were
found; however, to keep solid comparative basis among
the studied groups and to compare ISH results with that
of the semi-quantitative real-time RT-PCR, no certain
scoring system was used. Instead, the percentage of the
positively stained cells out of total cells was used; exam-
ples of ISH mRNA staining are shown in Figure 5. On
the other hand, stained SGMB DNA appeared as chains
of dark tiny spots scattered throughout the examined
sections representing the colonizing SGMB; examples of
ISH staining of SGMB DNA are shown in Figure 6. The
interpretation of ISH staining by S.g-sodA probe was
assessed qualitatively. Since the presence of SGMB DNA
in colorectal tissues is considered abnormal, any positive
detection of SGMB DNA was considered positive.
Statistical analysis
Statistical analysis was conducted using SPSS software ver-
sion 14.2.1 and MS EXCEL 2007. The normality of quanti-
tative continuous data was tested by Kolmogorov-Smirnov
test. Data in the current study were found to be normally
distributed; therefore, quantitative data were expressed in
mean ± SEM and, therefore, parametric tests were used.
Depending on F-test for variance, univariate and multivari-
ate student t-test were used for measuring the significance
of difference between two means. Categorized qualitative
(frequency) data were treated by chi square for indepen-
dence or Fisher’s exact test, when needed, for measuring
the significance of association among different studied
groups. Moreover, Pearson correlation coefficient (r) was
used along with ANOVA test for assessing the significance
of correlation. For SGMB cell count, or SGMB load, in
colorectal tissues, it was transformed into logarithmic
values in terms of log10 copy number per gram (log10 CN/
g). The mean log10 CN/g was calculated by averaging the
individual log10 CN/g values [47]. 95% confidence interval
(CI) of mean log10 CN/g was used to express uncertainty
measurements of bacterial counts and to measure the
significance of difference among different groups. P values
< 0.05 were considered significant.
List of abbreviations
CN: copy number; CRC: colorectal cancer; Ct: threshold cycle; CRC-w/bac:
colorectal cancer with bacteremia; CRC-wo/bac: colorectal cancer without
bacteremia; ISH: in situ hybridization; NSBS: negative standard bacterial; PSBS:
positive standard bacterial; SGMB: streptococcus gallolyticus member
Figure 6 Examples of ISH staining of SGMB DNA at 400X in colorectal tissues of (A) TU SGMB+ve-CRC-w/bac and (B) NTU SGMB+ve-
CRC-wo/bac. SGMB DNA staining was shown as chains of stained tiny dark spots which are pointed by black arrows. No distinctive pattern of
distribution of the positively stained SGMB was seen throughout stained sections.
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bacteria; SGMB+ve: SGMB positive; SGMB-ve: SGMB negative; sodA:
superoxide dismutase A; TU: tumorous; NTU: non-tumorous.
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